In a letter today, AHA asked GE Healthcare to provide additional information to help member hospitals manage the current shortage of GE intraveneous contrast mediaproducts for computed tomography imaging. AHA said supply disruptions, such as the shortage caused by the shutdown of GE factories for these products in Shanghai due to a COVID-19 outbreak, can present significant care delivery challenges for hospitals, and that certain additional information would immensely help hospitals manage patient needs during the shortages.

Related News Articles

Headline
ASHP tracked a record 323 active drug shortages during the first quarter of 2024, surpassing the previous record of 320 shortages in 2014.“Some of the most…
Headline
The Department of Health and Human Services April 2 released a white paper proposing policy solutions for Congress and others to prevent drug shortages and…
Headline
In a statement submitted to the House Ways and Means Committee for a hearing Feb. 6 on chronic drug shortages, AHA recommended Congress enact legislation to…
Headline
Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a House version of the Mapping America’s Pharmaceutical Supply Act, legislation…
Headline
In a statement submitted to the Senate Finance Committee Dec. 5 for a hearing on drug shortages and potential health policy solutions, AHA reiterated its…
Headline
The House Energy and Commerce Committee held a hearing on legislative proposals to prevent and respond to generic drug shortages. In comments submitted…